Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C.Difficile Diarrhea”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Large-scale testing (Phase 3)Ended earlyNCT00177775
What this trial is testing

Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Who this might be right for
Positive C-Diff Culture
University of Pittsburgh 60
Early research (Phase 1)Ended earlyNCT00772954
What this trial is testing

Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Diarrhea
Sanofi 36
Testing effectiveness (Phase 2)Study completedNCT03806803
What this trial is testing

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridia Difficile ColitisClostridium Difficile Diarrhea
University of Alberta 138
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Very early researchWithdrawnNCT04246151
What this trial is testing

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

Who this might be right for
Clostridium Difficile ColonizationClostridium Difficile Diarrhea
Hamilton Health Sciences Corporation
Early research (Phase 1)Ended earlyNCT03793686
What this trial is testing

Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Diarrhea
Prolacta Bioscience 26
Early research (Phase 1)Enrolling By InvitationNCT01868373
What this trial is testing

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Who this might be right for
Active C. Difficile Colitis
Baylor College of Medicine 12
Not applicableUnknownNCT03964844
What this trial is testing

Clostridium Difficile Infection (CDI) in Hematologic Patients.

Who this might be right for
C.Difficile Diarrhea
Hospital General Universitario Gregorio Marañon 450
Testing effectiveness (Phase 2)Looking for participantsNCT04305769
What this trial is testing

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Who this might be right for
Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia 260
Not applicableUnknownNCT03141775
What this trial is testing

Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Diarrhea
University of Cologne 541
Large-scale testing (Phase 3)Study completedNCT00468728
What this trial is testing

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 535
Not applicableLooking for participantsNCT06839209
What this trial is testing

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium; Difficile, As Cause of Disease Classified ElsewhereClostridium Difficile Diarrhea
ABResearch S.r.l. 18
Large-scale testing (Phase 3)Study completedNCT00106509
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisPseudomembranous Colitis
Genzyme, a Sanofi Company 520
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Large-scale testing (Phase 3)Study completedNCT03244644
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

Who this might be right for
Clostridium Difficile Infection (CDI)
Rebiotix Inc. 320
Large-scale testing (Phase 3)WithdrawnNCT02801656
What this trial is testing

Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea

Who this might be right for
Clostridium Difficile
Memorial University of Newfoundland
Not applicableStudy completedNCT04854941
What this trial is testing

Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection

Who this might be right for
Coronavirus Infection
I.M. Sechenov First Moscow State Medical University 200
Large-scale testing (Phase 3)Looking for participantsNCT06237452
What this trial is testing

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection Recurrence+7 more
Vedanta Biosciences, Inc. 852
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Load More Results